TwinStrand's biochemistry and software-based solution enables researchers and clinicians to detect genetic 'needles in a haystack.' By identifying ultra-low frequency DNA mutations with a resolution 10,000-fold greater than conventional tools on the market, TwinStrand enables detection, quantification, and characterization of variants that were previously undetectable.
Market
Genetic Research and Clinical Diagnostics
Location
Seattle,
WA,
USA
Coinvestors
Alexandria Venture Investments, Madrona Venture Group, Ridgeback Capital Management